U-Omp19 from Brucella abortus is a useful adjuvant for vaccine formulations against Salmonella infection in mice

Gabriela S. Risso, Marianela V. Carabajal, Laura A. Bruno, Andrés E. Ibañez, Lorena M. Coria, Karina A. Pasquevich, Seung Joo Lee, Stephen J Mcsorley, Gabriel Briones, Juliana Cassataro

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Most pathogens infect through mucosal surfaces, and parenteral immunization typically fails to induce effective immune responses at these sites. Development of oral-administered vaccines capable of inducing mucosal as well as systemic immunity while bypassing the issues of antigen degradation and immune tolerance could be crucial for the control of enteropathogens. This study demonstrates that U-Omp19, a bacterial protease inhibitor with immunostimulatory features, coadministered with Salmonella antigens by the oral route, enhances mucosal and systemic immune responses in mice. U-Omp19 was able to increase antigen-specific production of IFN-γ and IL-17 and mucosal (IgA) antibody response. Finally, oral vaccination with U-Omp19 plus Salmonella antigens conferred protection against virulent challenge with Salmonella Typhimurium, with a significant reduction in bacterial loads. These findings prove the efficacy of this novel adjuvant in the Salmonella infection model and support the potential of U-Omp19 as a suitable adjuvant in oral vaccine formulations against mucosal pathogens requiring T helper (Th)1-Th17 protective immune responses.

Original languageEnglish (US)
Article number171
JournalFrontiers in Immunology
Volume8
Issue numberFEB
DOIs
StatePublished - Feb 17 2017

Fingerprint

Brucella abortus
Salmonella Infections
Vaccines
Antigens
Salmonella
Mucosal Immunity
Immune Tolerance
Interleukin-17
Bacterial Load
Salmonella typhimurium
Protease Inhibitors
Immunoglobulin A
Antibody Formation
Immunity
Immunization
Vaccination

Keywords

  • Adjuvant
  • Salmonella Typhimurium
  • T helper 1
  • T helper 17
  • Vaccination

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Risso, G. S., Carabajal, M. V., Bruno, L. A., Ibañez, A. E., Coria, L. M., Pasquevich, K. A., ... Cassataro, J. (2017). U-Omp19 from Brucella abortus is a useful adjuvant for vaccine formulations against Salmonella infection in mice. Frontiers in Immunology, 8(FEB), [171]. https://doi.org/10.3389/fimmu.2017.00171

U-Omp19 from Brucella abortus is a useful adjuvant for vaccine formulations against Salmonella infection in mice. / Risso, Gabriela S.; Carabajal, Marianela V.; Bruno, Laura A.; Ibañez, Andrés E.; Coria, Lorena M.; Pasquevich, Karina A.; Lee, Seung Joo; Mcsorley, Stephen J; Briones, Gabriel; Cassataro, Juliana.

In: Frontiers in Immunology, Vol. 8, No. FEB, 171, 17.02.2017.

Research output: Contribution to journalArticle

Risso, GS, Carabajal, MV, Bruno, LA, Ibañez, AE, Coria, LM, Pasquevich, KA, Lee, SJ, Mcsorley, SJ, Briones, G & Cassataro, J 2017, 'U-Omp19 from Brucella abortus is a useful adjuvant for vaccine formulations against Salmonella infection in mice', Frontiers in Immunology, vol. 8, no. FEB, 171. https://doi.org/10.3389/fimmu.2017.00171
Risso, Gabriela S. ; Carabajal, Marianela V. ; Bruno, Laura A. ; Ibañez, Andrés E. ; Coria, Lorena M. ; Pasquevich, Karina A. ; Lee, Seung Joo ; Mcsorley, Stephen J ; Briones, Gabriel ; Cassataro, Juliana. / U-Omp19 from Brucella abortus is a useful adjuvant for vaccine formulations against Salmonella infection in mice. In: Frontiers in Immunology. 2017 ; Vol. 8, No. FEB.
@article{3b5125fe01164644a42c69af24f96c86,
title = "U-Omp19 from Brucella abortus is a useful adjuvant for vaccine formulations against Salmonella infection in mice",
abstract = "Most pathogens infect through mucosal surfaces, and parenteral immunization typically fails to induce effective immune responses at these sites. Development of oral-administered vaccines capable of inducing mucosal as well as systemic immunity while bypassing the issues of antigen degradation and immune tolerance could be crucial for the control of enteropathogens. This study demonstrates that U-Omp19, a bacterial protease inhibitor with immunostimulatory features, coadministered with Salmonella antigens by the oral route, enhances mucosal and systemic immune responses in mice. U-Omp19 was able to increase antigen-specific production of IFN-γ and IL-17 and mucosal (IgA) antibody response. Finally, oral vaccination with U-Omp19 plus Salmonella antigens conferred protection against virulent challenge with Salmonella Typhimurium, with a significant reduction in bacterial loads. These findings prove the efficacy of this novel adjuvant in the Salmonella infection model and support the potential of U-Omp19 as a suitable adjuvant in oral vaccine formulations against mucosal pathogens requiring T helper (Th)1-Th17 protective immune responses.",
keywords = "Adjuvant, Salmonella Typhimurium, T helper 1, T helper 17, Vaccination",
author = "Risso, {Gabriela S.} and Carabajal, {Marianela V.} and Bruno, {Laura A.} and Iba{\~n}ez, {Andr{\'e}s E.} and Coria, {Lorena M.} and Pasquevich, {Karina A.} and Lee, {Seung Joo} and Mcsorley, {Stephen J} and Gabriel Briones and Juliana Cassataro",
year = "2017",
month = "2",
day = "17",
doi = "10.3389/fimmu.2017.00171",
language = "English (US)",
volume = "8",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S. A.",
number = "FEB",

}

TY - JOUR

T1 - U-Omp19 from Brucella abortus is a useful adjuvant for vaccine formulations against Salmonella infection in mice

AU - Risso, Gabriela S.

AU - Carabajal, Marianela V.

AU - Bruno, Laura A.

AU - Ibañez, Andrés E.

AU - Coria, Lorena M.

AU - Pasquevich, Karina A.

AU - Lee, Seung Joo

AU - Mcsorley, Stephen J

AU - Briones, Gabriel

AU - Cassataro, Juliana

PY - 2017/2/17

Y1 - 2017/2/17

N2 - Most pathogens infect through mucosal surfaces, and parenteral immunization typically fails to induce effective immune responses at these sites. Development of oral-administered vaccines capable of inducing mucosal as well as systemic immunity while bypassing the issues of antigen degradation and immune tolerance could be crucial for the control of enteropathogens. This study demonstrates that U-Omp19, a bacterial protease inhibitor with immunostimulatory features, coadministered with Salmonella antigens by the oral route, enhances mucosal and systemic immune responses in mice. U-Omp19 was able to increase antigen-specific production of IFN-γ and IL-17 and mucosal (IgA) antibody response. Finally, oral vaccination with U-Omp19 plus Salmonella antigens conferred protection against virulent challenge with Salmonella Typhimurium, with a significant reduction in bacterial loads. These findings prove the efficacy of this novel adjuvant in the Salmonella infection model and support the potential of U-Omp19 as a suitable adjuvant in oral vaccine formulations against mucosal pathogens requiring T helper (Th)1-Th17 protective immune responses.

AB - Most pathogens infect through mucosal surfaces, and parenteral immunization typically fails to induce effective immune responses at these sites. Development of oral-administered vaccines capable of inducing mucosal as well as systemic immunity while bypassing the issues of antigen degradation and immune tolerance could be crucial for the control of enteropathogens. This study demonstrates that U-Omp19, a bacterial protease inhibitor with immunostimulatory features, coadministered with Salmonella antigens by the oral route, enhances mucosal and systemic immune responses in mice. U-Omp19 was able to increase antigen-specific production of IFN-γ and IL-17 and mucosal (IgA) antibody response. Finally, oral vaccination with U-Omp19 plus Salmonella antigens conferred protection against virulent challenge with Salmonella Typhimurium, with a significant reduction in bacterial loads. These findings prove the efficacy of this novel adjuvant in the Salmonella infection model and support the potential of U-Omp19 as a suitable adjuvant in oral vaccine formulations against mucosal pathogens requiring T helper (Th)1-Th17 protective immune responses.

KW - Adjuvant

KW - Salmonella Typhimurium

KW - T helper 1

KW - T helper 17

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=85014410562&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014410562&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2017.00171

DO - 10.3389/fimmu.2017.00171

M3 - Article

VL - 8

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

IS - FEB

M1 - 171

ER -